Matthias Behrend

PLACEBO-CONTROLLED STUDY OF MYCOPHENOLATE MOFETIL COMBINED WITH CYCLOSPORINE AND CORTICOSTEROIDS FOR PREVENTION OF ACUTE REJECTION

Josep M. Grinyó, CG Groth, R. Pichlmayr et al. · Data Archiving and Networked Services (DANS) · 1995 · 979 citations

Pharmacy, Pharmacology, Pharmacotherapy +9

MULTICENTER RANDOMIZED TRIAL COMPARING TACROLIMUS (FK506) AND CYCLOSPORINE IN THE PREVENTION OF RENAL ALLOGRAFT REJECTION1

A. David Mayer, Jan Dmitrewski, Jean-Paul Squifflet et al. · Transplantation · 1997 · 733 citations

Medicine, Immunology, Kidney Transplantation +9

Mycophenolate mofetil in renal transplantation: 3-year results from the placebo-controlled trial

Matthias Behrend, Josep M. Grinyó, Yves Vanrenterghem et al. · University of Groningen research database (University of Groningen / Centre for Information Technology) · 1999 · 201 citations

Medicine, Nephrology, Pharmacotherapy +15

Expression patterns of leukocyte adhesion ligand molecules on human liver endothelia. Lack of ELAM-1 and CD62 inducibility on sinusoidal endothelia and distinct distribution of VCAM-1, ICAM-1, ICAM-2, and LFA-3.

Gustav Steinhoff, Matthias Behrend, B. Schrader et al. · PubMed · 1993 · 192 citations

Life Sciences, Cell Biology, Immunology +17

Impact of Lymphadenectomy on the Oncologic Outcome of Patients With Adrenocortical Carcinoma

J. Reibetanz, Christian Jurowich, Ilknur Erdogan et al. · Annals of Surgery · 2011 · 175 citations

Medicine, Oncology, Surgery +17